A project to explore the possibility of bringing people back from the dead was given the green light by health watchdogs earlier this year and researchers are working to test efficacy of the project.
US biotech company Bioquark Inc has been granted ethical permission to begin the groundbreaking trials.
The project will involve 20 patients who have been declared brain dead as the result of a traumatic brain injury and will “test whether parts of their central nervous system can be brought back to life” using a combination of different therapies, reported the Daily Telegraph.
“This represents the first trial of its kind and another step towards the eventual reversal of death in our lifetime,” says Dr Ira Pastor, the chief executive of Bioquark.
The team started working with a hospital to identify families where there may be a religious or medical barrier to organ donation.
The test subjects will be monitored for signs of regeneration, particularly in the upper spinal cord, which controls independent breathing and the heartbeat.
According to NZHerald, The treatment will run over six weeks and they will be monitored for several months using brain imaging equipment to look for signs of regeneration, particularly in the lowest region of the brain stem, which controls independent breathing and heartbeat.